Clinical
Studies:
Department of Pharmacology
and Molecular Sciences, Johns Hopkins University School of Medicine
Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and
the risk of developing gastric cancer.
Department of Epidemiology, Johns
Hopkins School of Hygiene and Public Health
The relationship of serum dehydroepiandrosterone and its sulfate to subsequent
cancer of the prostate.
Department of Urology, Mayo Clinic
Treatment of endocrinologic male sexual dysfunction.
New England Journal of Medicine
A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular
disease.
Department of Family Practice and
Community Medicine, University of Texas Medical School at Houston
Is it andropause? Recognizing androgen deficiency in aging men.
St. Louis University Medical School
Testosterone and frailty.
New England Research Institutes
Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective
results from the Massachusetts Male Aging Study.
Department of Molecular and Cell
Biology, University of California, Berkeley
Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha
secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages.
Division of Geriatric Medicine, St.
Louis University Health Sciences Center
Andropause, testosterone therapy, and quality of life in aging men.
Clinical and Administrative Pharmacy
Division, University of Iowa
Testosterone and andropause: the feasibility of testosterone replacement therapy
in elderly men.
Department of Urology, Case Western
Reserve University School of Medicine
Prostate-specific antigen changes in hypogonadal men treated with testosterone
replacement.
University of Washington School of
Medicine
Testosterone supplementation therapy for older men: potential benefits and
risks.
University of Tampa and the Osteoporosis
Testing Center
Hormonal decline in elderly men and male menopause.
References:
Cleve Clin J Med. 2000 Dec;67(12):880-2.
Andropause, testosterone
therapy, and quality of life in aging men.
Mayo Clin Proc. 2000 Jan;75 Suppl:S40-5.
Treatment of endocrinologic
male sexual dysfunction.
N Engl J Med. 1986 Dec 11;315(24):1519-24. Related Articles,
Links
A prospective study of dehydroepiandrosterone sulfate, mortality,
and cardiovascular disease.
J Urol. 2002 Nov;168(5):2070-3.
A double-blind crossover study evaluating the efficacy of korean
red ginseng in patients with erectile dysfunction: a preliminary report.
Postgrad Med. 2004 Jan;115(1):62-6.
Is it andropause? Recognizing androgen deficiency in aging men.
Clin Geriatr Med. 1997 Nov;13(4):685-95.
Testosterone and frailty.
Am J Epidemiol. 2001 Jan 1;153(1):79-89
Low dehydroepiandrosterone
and ischemic heart disease in middle-aged men: prospective results
from the Massachusetts Male Aging Study.
FEBS Lett. 2000 Jan 14;465(2-3):93-7.
Activity of monomeric,
dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion,
and NF-kappaB-dependent gene expression in RAW 264.7 macrophages.
Pharmacotherapy. 1999 Aug;19(8):951-6.
Testosterone and andropause:
the feasibility of testosterone replacement therapy in elderly men.
J Androl. 2002 Nov-Dec;23(6):922-6.
Prostate-specific antigen changes in hypogonadal men treated
with testosterone replacement.
J Am Geriatr Soc. 2003 Jan;51(1):101-15; discussion 115.
Testosterone supplementation therapy for older men: potential
benefits and risks.
Cancer Epidemiol Biomarkers Prev. 1993 May-Jun;2(3):219-21. Related
Articles, Links
The relationship of serum dehydroepiandrosterone
and its sulfate to subsequent cancer of the prostate.
Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb;2(1):33-5. Related Articles,
Links
Serum levels of dehydroepiandrosterone and dehydroepiandrosterone
sulfate and the risk of developing gastric cancer.
Geriatr Nurs. 2001 Jan-Feb;22(1):24-7; quiz 28.
Hormonal decline
in elderly men and male menopause.
Free Radic Biol Med. 1999 Sep;27(5-6):704-24.
Antioxidant activity
and biologic properties of a procyanidin-rich extract from pine (Pinus
maritima) bark, pycnogenol.
J Cardiovasc Pharmacol. 1998 Oct;32(4):509-15.
Endothelium-dependent
vascular effects of Pycnogenol.
Eur Urol. 2002 Feb;41(2):113-20.
Androgen replacement therapy
and prostate safety.
Aging Male. 2002 Mar;5(1):47-51.
Effects of androgen supplementation
therapy on partial androgen deficiency in the aging male: a preliminary
study.
Int J Clin Pharmacol Ther. 2002 Apr;40(4):158-68.
A review of
the French maritime pine bark extract (Pycnogenol), a herbal medication
with a diverse clinical pharmacology.
Exp Gerontol. 2001 Nov;36(10):1739-47. Related Articles, Links
Dehydroepiandrosterone,
ageing and immune activation.
Phytother Res. 2000 Sep;14(6):472-3.
Inhibition of lipogenesis by pycnogenol.
Urology. 2000 May;55(5):755-8. Related Articles, Links
Serum
dehydroepiandrosterone sulfate concentrations in men with erectile
dysfunction.
Int J Impot Res. 1999 Dec;11(6):343-52.
Testosterone supplementation
in the aging male.
Phytother Res. 1999 Nov;13(7):619-20.
Stimulation of lipolysis by pycnogenol.
J Sex Marital Ther. 2003 May-Jun;29(3):207-13.
Treatment of
erectile dysfunction with pycnogenol and L-arginine.
Int J Impot Res. 2003 Aug;15 Suppl 4:S3-8.
Declining testicular function in aging men.
Asian J Androl. 2003 Sep;5(3):243-6.
Clinical trial of Butea
superba, an alternative herbal treatment for erectile dysfunction.
J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):349-55.
Androgen deficiency in the aging male: benefits and risks of
androgen supplementation.
Aging Male. 2003 Sep;6(3):184-99.
Testosterone supplementation:
why and for whom?
Reprod Biomed Online. 2003 Oct-Nov;7(4):385-91.
The role of food supplements in the treatment of the infertile
man.
J Reprod Med. 2002 Oct;47(10):821-4.
Improvement in sperm quality
and function with French maritime pine tree bark extract.
Altern Med Rev. 2004 Mar;9(1):4-16.
Nutrients and botanicals
for erectile dysfunction: examining the evidence.
|
